Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Perampanel as Adjunctive Therapy in Children 1 mo - 2 years with Epilepsy
Full IRB Study Title:
An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy
IRB Study ID: 1057929
For complete study information, please view the study on clinicaltrials.gov
Lead Investigator
Michael Kohrman, MD
Director, Pediatric Neurology; Pediatric Neurologist
Pediatric Epilepsy ProgramTuberous Sclerosis ClinicNeuroDevelopmental Science Center
